Black Diamond Therapeutics
BDTX
BDTX
100 hedge funds and large institutions have $206M invested in Black Diamond Therapeutics in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
-2
Holders Change %
-1.96%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
23
Reduced
37
Closed
14
Calls
$433K
Puts
$705K
Net Calls
-$272K
Net Calls Change
+$198K
Top Buyers
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$2.1M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$1.64M |
| 3 |
Morgan Stanley
New York
|
+$1.35M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.35M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.1M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.9M |
| 2 |
DM
Deerfield Management
New York
|
-$2.43M |
| 3 |
Two Sigma Investments
New York
|
-$993K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$777K |
| 5 |
Millennium Management
New York
|
-$699K |
